Concepedia

Publication | Open Access

LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study

DOIFull Paper Access

183

Citations

16

References

2013

Year

Xavier Bertagna, Rosario Pivonello, Maria Fleseriu, Yiming Zhang, Paul Robinson, Ann E. Taylor, Catherine E. Watson, Mario Maldonado, Amir H. Hamrahian, Marco Boscaro,
The Journal of Clinical Endocrinology & Metabolism

Abstract

LCI699 was efficacious and well tolerated in patients with Cushing's disease enrolled in this proof-of-concept study.

References

YearCitations

Page 1